These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 20164318)

  • 1. Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting.
    Gullett NP; Hebbar G; Ziegler TR
    Am J Clin Nutr; 2010 Apr; 91(4):1143S-1147S. PubMed ID: 20164318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approved pharmacologic interventions for wasting: an overview and lessons learned.
    Mann M
    J Nutr; 1999 Jan; 129(1S Suppl):303S-305S. PubMed ID: 9915919
    [No Abstract]   [Full Text] [Related]  

  • 3. Ghrelin: from discovery to cancer cachexia therapy.
    Molfino A; Formiconi A; Rossi Fanelli F; Muscaritoli M
    Curr Opin Clin Nutr Metab Care; 2014 Sep; 17(5):471-6. PubMed ID: 24905862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new look at an old drug for the treatment of cancer cachexia: megestrol acetate.
    Argilés JM; Anguera A; Stemmler B
    Clin Nutr; 2013 Jun; 32(3):319-24. PubMed ID: 23395103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials update in human immunodeficiency virus wasting.
    Muurahainen N; Mulligan K
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):104-11. PubMed ID: 9625392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of ghrelin and ghrelin analogues in wasting disease.
    Kamiji MM; Inui A
    Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):443-51. PubMed ID: 18542005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting.
    Mulligan K; Schambelan M
    Int J Cardiol; 2002 Sep; 85(1):151-9. PubMed ID: 12163220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches to the AIDS Wasting Syndrome.
    Corcoran C
    Posit Dir News; 1998; 10(2):24-7. PubMed ID: 11365549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acylated and unacylated ghrelin administration to blunt muscle wasting.
    Reano S; Graziani A; Filigheddu N
    Curr Opin Clin Nutr Metab Care; 2014 May; 17(3):236-40. PubMed ID: 24572833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism and novel therapeutic approaches to wasting in chronic disease.
    Ebner N; Springer J; Kalantar-Zadeh K; Lainscak M; Doehner W; Anker SD; von Haehling S
    Maturitas; 2013 Jul; 75(3):199-206. PubMed ID: 23664695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety.
    Orr R; Fiatarone Singh M
    Drugs; 2004; 64(7):725-50. PubMed ID: 15025546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anabolic steroids.
    Treat Rev; 1995 May; (no 18):8. PubMed ID: 11362596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation.
    Musolino V; Palus S; Tschirner A; Drescher C; Gliozzi M; Carresi C; Vitale C; Muscoli C; Doehner W; von Haehling S; Anker SD; Mollace V; Springer J
    J Cachexia Sarcopenia Muscle; 2016 Dec; 7(5):555-566. PubMed ID: 27239419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer.
    Dalton JT; Taylor RP; Mohler ML; Steiner MS
    Curr Opin Support Palliat Care; 2013 Dec; 7(4):345-51. PubMed ID: 24189892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone replacement, weight lifting help wasting.
    AIDS Alert; 1996 Jun; 11(6):suppl 1-2. PubMed ID: 11363546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of cachexia: an overview of recent developments.
    von Haehling S; Anker SD
    J Am Med Dir Assoc; 2014 Dec; 15(12):866-72. PubMed ID: 25455531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in understanding and treating cardiac cachexia: highlights from the 5th Cachexia Conference.
    von Haehling S; Stepney R; Anker SD
    Int J Cardiol; 2010 Oct; 144(3):347-9. PubMed ID: 20561693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia.
    Loprinzi CL; Kugler JW; Sloan JA; Mailliard JA; Krook JE; Wilwerding MB; Rowland KM; Camoriano JK; Novotny PJ; Christensen BJ
    J Clin Oncol; 1999 Oct; 17(10):3299-306. PubMed ID: 10506633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of beta-adrenoceptor signaling in skeletal muscle: therapeutic implications for muscle wasting disorders.
    Koopman R; Ryall JG; Church JE; Lynch GS
    Curr Opin Clin Nutr Metab Care; 2009 Nov; 12(6):601-6. PubMed ID: 19741516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac cachexia: a systematic overview.
    von Haehling S; Lainscak M; Springer J; Anker SD
    Pharmacol Ther; 2009 Mar; 121(3):227-52. PubMed ID: 19061914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.